Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Viemed Healthcare, Inc. (VMD : NSDQ)

• Company Description    Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. Number of Employees: 1,382

• Price / Volume Information    Yesterday's Closing Price: $9.49 Daily Weekly Monthly 20 Day Moving Average: 268,234 shares Shares Outstanding: 38.34 (millions) Market Capitalization: $363.82 (millions) Beta: 1.15 52 Week High: $10.18 52 Week Low: $5.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.84% -6.92% 12 Week 14.34% 4.59% Year To Date 27.73% 16.56%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 625 East Kaliste Saloom Road - Lafayette,LA 70508 USA ph: 337-504-3802 fax: - glen@bristolir.com http://www.viemed.com

• General Corporate Information    Officers Casey Hoyt - Chief Executive Officer Randy Dobbs - Chairman W. Todd Zehnder - Chief Operating Officer Trae Fitzgerald - Chief Financial Officer Sabrina Heltz - Director Peer Information Viemed Healthcare, Inc. (BJCT) Viemed Healthcare, Inc. (CADMQ) Viemed Healthcare, Inc. (APNO) Viemed Healthcare, Inc. (UPDC) Viemed Healthcare, Inc. (IMTIQ) Viemed Healthcare, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 92663R105 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 38.34 Most Recent Split Date: (:1) Beta: 1.15 Market Capitalization: $363.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.10 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.44 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 21.57 Trailing 12 Months: 25.65 PEG Ratio: - Price Ratios Price/Book: 2.50 Price/Cash Flow: 8.24 Price / Sales: 1.27 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: -57.14% Sales Growth vs. Year Ago Period: 27.54% vs. Previous Quarter: -1.01% ROE 03/31/26 - 10.52 12/31/25 - 10.72 09/30/25 - 9.95 ROA 03/31/26 - 7.60 12/31/25 - 7.82 09/30/25 - 7.34 Current Ratio 03/31/26 - 1.22 12/31/25 - 1.18 09/30/25 - 1.13 Quick Ratio 03/31/26 - 1.10 12/31/25 - 1.06 09/30/25 - 1.01 Operating Margin 03/31/26 - 5.20 12/31/25 - 5.53 09/30/25 - 5.34 Net Margin 03/31/26 - 5.20 12/31/25 - 5.53 09/30/25 - 5.34 Pre-Tax Margin 03/31/26 - 7.71 12/31/25 - 8.05 09/30/25 - 7.88 Book Value 03/31/26 - 3.80 12/31/25 - 3.78 09/30/25 - 3.56 Inventory Turnover 03/31/26 - 24.53 12/31/25 - 23.98 09/30/25 - 23.30 Debt-to-Equity 03/31/26 - 0.06 12/31/25 - 0.08 09/30/25 - 0.14 Debt-to-Capital 03/31/26 - 5.41 12/31/25 - 7.29 09/30/25 - 12.63

Powered by Zacks Investment Research ©